FDA NDC Directory · JSON-LD · Markdown

COMETRIQ

NDC 42388-013 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic namecabozantinib
Labeler / ManufacturerExelixis, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA203756
Dosage form / routeCAPSULE · ORAL
Active ingredientsCABOZANTINIB S-MALATE (20 mg/1)
Marketing started20121129
Package count1

External sources

Source: openFDA. Public-domain (CC0).